scispace - formally typeset
M

Mauro Provinciali

Researcher at Advanced Technology Center

Publications -  214
Citations -  5342

Mauro Provinciali is an academic researcher from Advanced Technology Center. The author has contributed to research in topics: Cytotoxic T cell & Population. The author has an hindex of 38, co-authored 200 publications receiving 4690 citations. Previous affiliations of Mauro Provinciali include Marche Polytechnic University & University of Perugia.

Papers
More filters
Journal ArticleDOI

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

TL;DR: The metformin-treatment significantly decreased the incidence and size of mammary adenocarcinomas in mice and increased the mean latency of the tumors, suggesting that the life-prolonging effects of calorie restriction are due to decreasing IGF-1 levels.
Journal ArticleDOI

Moving against frailty: does physical activity matter?

TL;DR: This review will address the role of physical activity on the most relevant components of frailty syndrome, with specific reference to sarcopenia, as a condition which frequently overlaps with frailty.
Journal ArticleDOI

Effect of resveratrol on the development of spontaneous mammary tumors in HER‐2/neu transgenic mice

TL;DR: It is demonstrated that Res supplementation delays the development and reduces the metastasizing capacity of spontaneous mammary tumors in HER‐2/neu transgenic mice.
Journal ArticleDOI

Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction.

TL;DR: The present paper aims at summarizing the data available on the existence of thyroid-immune interactions, and at analyzing the possible integration between pituitary-thyroid hormones and immune factors in favoring the development and maintenance of both thymic and peripheral immune efficiency.
Journal ArticleDOI

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

TL;DR: The data demonstrate the effectiveness of DNA vaccination using truncated Neu plasmids in inducing antitumor protection in a spontaneous mammary tumor model.